Roth Capital analyst David Bain raised the price target on USANA Health Sciences Inc. (NYSE: USNA) to $126.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Form 4 USANA HEALTH SCIENCES For: Feb 08 Filed by: Noot WalterFebruary 9, 2021 6:34 PM Form 4 USANA HEALTH SCIENCES For: Feb 06 Filed by: Mulham David MulhamFebruary 9, 2021 6:33 PM Form 4 USANA HEALTH SCIENCES For: Feb 06 Filed by: Macuga Daniel A.February 9, 2021 6:33 PM Form 4 USANA HEALTH SCIENCES For: Feb 08 Filed by: Jones Paul A.February 9, 2021 6:33 PM Form 4 USANA HEALTH SCIENCES For: Feb 08 Filed by: IIEKKING G DOUGFebruary 9, 2021 6:32 PM Form 4 USANA HEALTH SCIENCES For: Feb 06 Filed by: Foukas JoshuaFebruary 9, 2021 6:32 PM Form 4 USANA HEALTH SCIENCES For: Feb 06 Filed by: Guest KevinFebruary 9, 2021 6:31 PM Form 4 USANA HEALTH SCIENCES For: Feb 06 Filed by: Brown JimFebruary 9, 2021 6:30 PM After-Hours Stock Movers 02/09: (GNFT) (MODN) (USNA) Higher; (VNRX) (XONE) (LMB) Lower (more...)February 9, 2021 6:01 PM Form 8-K USANA HEALTH SCIENCES For: Feb 09February 9, 2021 4:36 PM USANA Health Sciences (USNA) Tops Q4 EPS by 44c, Offers GuidanceFebruary 9, 2021 4:20 PM USANA Health Sciences Finishes Strong 2020 with 14.5% Fourth Quarter Net Sales Growth and 32.6% Diluted EPS GrowthFebruary 9, 2021 4:17 PM